Antihistamines for Hives: Which to Use and When Doses Increase

What you need to know

• Second-generation antihistamines (cetirizine, loratadine, fexofenadine) are the recommended first-line treatment for hives.
• They're preferred over sedating first-generation antihistamines because they control itching and welts with far less drowsiness, which matters for a condition often treated daily.
• When standard doses don't control symptoms, AAAAI/ACAAI guidelines describe raising the dose of a second-generation antihistamine — sometimes up to about fourfold — but this is a clinician's decision, not something to do on your own.
• Acute hives last less than six weeks; chronic hives (chronic urticaria) persist for six weeks or longer and warrant medical evaluation.
• Antihistamines relieve hives but don't treat an underlying cause; persistent or unexplained hives should be evaluated.
• Hives with swelling of the lips, tongue, or throat, or with difficulty breathing, can signal a severe allergic reaction and are an emergency.

Why Antihistamines Help Hives

Hives (urticaria) are raised, itchy welts caused by the release of histamine and other chemicals in the skin, which makes small blood vessels leak and nerve endings itch. Antihistamines block the H1 histamine receptor, which is why they reduce both the itch and the welts. Because histamine is central to how hives form, antihistamines are the mainstay of treatment for most people.

Why Second-Generation Is First-Line

Guidelines from the AAAAI and ACAAI recommend second-generation H1 antihistamines — such as cetirizine, loratadine, and fexofenadine — as the first-line treatment for hives. They're favored over older first-generation antihistamines because they control symptoms with much less sedation and fewer anticholinergic side effects, which matters because hives, especially chronic hives, are often treated with regular daily dosing over weeks or longer. Taking them on a scheduled basis, rather than only when welts appear, is generally how they're used for ongoing hives.

When Standard Doses Aren't Enough

If a standard dose doesn't control the hives, current guidelines describe a stepwise approach: increasing the dose of a second-generation antihistamine, in some cases up to about four times the standard amount, before adding other treatments. This higher dosing is an established part of urticaria guidelines, but it is a decision made and supervised by a clinician — this page doesn't provide dosing, and you shouldn't multiply your own dose without medical guidance. Some guidelines also describe combining agents or adding other therapies when high-dose antihistamines still aren't enough.

Acute vs. Chronic Hives

For the broader picture of what hives are and their causes, see our hives (urticaria) guide.

When hives come with swelling

Hives sit on the surface of the skin. Angioedema is the same process happening deeper, producing swelling rather than raised weals, and the two travel together far more often than most people expect.

A clinical review of chronic urticaria reports that “nearly 40% of patients experience concurrent angioedema, most often involving the lips, eyelids, genitals, or extremities”. It also notes that angioedema “often persists for up to 72 hours”, which is considerably longer than an individual hive and explains why swelling can linger after the rash has settled.

Swelling in those sites is uncomfortable rather than dangerous in itself. The distinction that matters is whether the airway is involved or the whole body is reacting, and that is not a judgement to make slowly.

The same review advises seeking “immediate medical attention if they experience throat or facial swelling, difficulty breathing, dizziness, or widespread hives accompanied by hypotension, which may indicate anaphylaxis”. Use a prescribed epinephrine auto-injector and call 911 rather than waiting to see whether an antihistamine handles it — see our anaphylaxis guide.

• Around 40% of chronic urticaria patients also get angioedema
• Most often lips, eyelids, genitals or extremities
• Swelling can last up to 72 hours, outlasting the hives themselves
• Throat or facial swelling, breathing difficulty, dizziness or hives with low blood pressure means emergency care
• An antihistamine is not the treatment for anaphylaxis — epinephrine is

Cold-triggered hives carry a risk the others do not

Physical urticarias — hives triggered by pressure, heat, exercise, sunlight or cold — are often treated as curiosities. The review notes that most of them “are generally limited to localized symptoms and rarely cause systemic reactions”. Cold urticaria is the exception, and the size of that exception is worth knowing.

It reports that “the pooled prevalence of anaphylaxis in cold urticaria is approximately 21%”, and that patients should “consider carrying an epinephrine autoinjector”. Roughly one in five is not a rare complication.

The mechanism makes the practical advice specific: a large area of skin cooling at once is the risk, which is why swimming in cold water is the scenario most often flagged rather than a cold drink or a chilly morning. If your hives appear on rewarming after cold exposure, that is worth raising with an allergist rather than managing with a daily tablet alone.

What happens after a standard dose stops being enough

The page above notes that doses are sometimes increased. It is worth setting out the shape of the whole plan, because it is a stepwise sequence a clinician works through rather than a single decision.

On escalation, the review states that “doses may be up-titrated every 2 to 4 weeks, up to 4 times the standard dose”. Two details in that sentence matter as much as the ceiling: the increases are spaced over weeks, and they are titrated rather than jumped to. This is a prescriber-guided process, not something to attempt from a supermarket packet.

If that is still not enough, guidelines suggest adding a second-generation H2 blocker such as famotidine or cimetidine, or a leukotriene receptor antagonist such as montelukast, before moving to biologic therapy. Beyond those, omalizumab is a recognised second-line option, and dupilumab is approved for patients aged 12 and older.

None of that is self-directed. The reason to know the sequence is so that a course of treatment failing does not read as the end of the road: there is a documented path beyond antihistamines, and reaching it is a reason to ask for a referral. See our guide to hives and urticaria.

• Up-titration is spaced every 2 to 4 weeks, up to four times the standard dose
• Escalation is prescriber-guided, not a self-service decision
• Add-on options include an H2 blocker or a leukotriene receptor antagonist
• Omalizumab is a recognised second-line therapy; dupilumab is approved from age 12
• Antihistamines failing is a reason to seek referral, not to give up

When to seek care

Practical next steps

Safe general steps

1. Start with a standard-dose second-generation antihistamine for mild hives
2. For ongoing hives, take it on a regular schedule rather than only when welts appear, as directed
3. Track triggers, timing, and how long episodes last to share with a clinician
4. See a clinician if hives persist toward or beyond six weeks

Actions that need medical guidance

• Increasing the antihistamine dose above the standard amount
• Evaluating chronic hives lasting six weeks or longer
• Adding other treatments when antihistamines alone aren't enough

Frequently asked questions

Sources

1. AAAAI/ACAAI Joint Task Force — Diagnosis and Management of Acute and Chronic Urticaria Guideline
2. StatPearls (NCBI/NIH) — Chronic Urticaria
3. StatPearls (NCBI/NIH) — Antihistamines

Medical disclaimer: This guide is for general education and isn't a substitute for personalized medical advice. It doesn't provide dosing. Always talk to a qualified healthcare professional about your symptoms and treatment.

Related guides